Database mg capsule diflucan ingredients database indicated for the treatment of candidal vaginitis, acute or recurrent. It should also be used for treatment of partners with associated candidal balanitis. Fluconazole should not diflucan ingredients database used in patients with known sensitivity diflucan ingredients database the drug, any of the inert ingredients or to related azole compounds.
Coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of mg per day or higher based upon results of a multiple diflucan ingredients database interaction study. Coadministration of other medicinal products known to prolong the QT interval and which are metabolised via database cytochrome P CYP 3A4 such as cisapride, astemizole, pimozide, quinidine and erythromycin are contraindicated list renagel vs renvela patients receiving fluconazole diflucan ingredients database section 4.
Ketoconazole is known to cause adrenal insufficiency, and this could also, although rarely seen, be applicable to fluconazole.
Adrenal insufficiency diflucan ingredients database to concomitant treatment with Prednisone is described in section 4. Fluconazole should be administered with caution to patients with liver dysfunction.
Fluconazole has been associated with rare cases of serious diflucan ingredients database toxicity including fatalities, primarily in patients with serious underlying medical conditions. Diflucan ingredients database cases of fluconazole-associated hepatotoxicity, no obvious relationship to total daily dose, duration of therapy, sex or age of patient has been observed.
Fluconazole hepatotoxicity has usually been reversible on discontinuation of therapy. Patients who develop abnormal liver function tests during diflucan ingredients database therapy should be monitored for the development of more serious hepatic injury. The patient should be informed of suggestive symptoms database serious hepatic effect important asthenia, anorexia, persistent nausea, vomiting and jaundice.
Fluconazole should be discontinued diflucan ingredients database clinical signs or symptoms consistent with liver disease develop that may be attributable to fluconazole and the patient should consult a physician. The concomitant use of fluconazole and database is therefore not recommended see section 4. Patients have rarely developed exfoliative cutaneous reactions, such as Check this out syndrome and toxic epidermal necrolysis, diflucan ingredients database treatment with fluconazole.
AIDS patients are more proventil manufacturer coupon 10 off 10 to cymbalta teenage depression anxiety development of severe cutaneous diflucan ingredients database to many drugs. If a rash, which is considered attributable to fluconazole, diflucan ingredients database in a patient treated for a superficial fungal diflucan ingredients, further therapy with this agent should be discontinued.
The coadministration of fluconazole at doses lower than mg per day with terfenadine database be carefully monitored see section 4. Some azoles, diflucan ingredients database fluconazole, have been associated with prolongation of the QT interval on the database.
Fluconazole causes QT prolongation via the inhibition of Rectifier Potassium. The QT prolongation caused by other medicinal products such as amiodarone may be amplified via the inhibition of cytochrome P CYP 3A4.
During post- marketing surveillance, there have been very rare cases of QT prolongation and torsade de pointes in patients diflucan ingredients fluconazole. These reports included diflucan ingredients database ill patients with database confounding risk factors, such as diflucan ingredients database heart disease, electrolyte abnormalities and concomitant medicines that may have been contributory.
Patients with hypokalemia and advanced database failure are at an increased risk go here diflucan ingredients database occurrence of life threatening ventricular arrhythmias and torsades de pointes. Fluconazole should be administered with caution to patients with these potentially diflucan ingredients database conditions.
Coadministration of other medicinal products diflucan ingredients database to prolong the QT interval and which are metabolised via the cytochrome P Database 3A4 are contraindicated see sections 4.
Fluconazole should be administered with caution to patients database renal dysfunction see also 4. Fluconazole is also an database of Diflucan ingredients Fluconazole Capsules contain lactose and should not be database to patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption.
The product intended for pharmacy availability without prescription will carry a leaflet which will advise the patient:. Do not use Fluconazole mg capsule article source first consulting your doctor: The product should never be used again if diflucan ingredients database patient experiences a rash or anaphylaxis follows the database of database drug. Recurrent use men and diflucan ingredients database Patients diflucan ingredients be advised to consult their physician if the symptoms have not been relieved within one week of taking Fluconazole.
A further capsule can be used if the source infection returns after 7 days. However, diflucan ingredients database the candidal infection recurs more than twice within six months, patients should be advised to consult see diflucan ingredients database physician.
This product contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Diflucan ingredients database have been reports of cardiac events including torsade de pointes in patients to whom fluconazole and cisapride were coadministered. A controlled study found that concomitant fluconazole mg once daily and cisapride 20mg four times database day yielded a significant increase in cisapride plasma levels and prolongation of QT interval. Concomitant treatment diflucan ingredients database fluconazole diflucan ingredients database cisapride is contraindicated see section 4.
Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving azole antifungals in conjunction with terfenadine, interaction studies have been performed. Diflucan ingredients database study at a mg daily dose of fluconazole failed to demonstrate a prolongation in QTc interval.
Another study at diflucan ingredients database mg and mg daily dose of fluconazole demonstrated that fluconazole taken in doses of mg per day or diflucan ingredients significantly increases plasma levels of terfenadine when taken concomitantly.
2018 ©